NeuroSense Therapeutics Ltd. (NRSN)
Nasdaq: NRSN · Pharmaceutical Preparations · Herzliya, IL · filing with the SEC since 2021
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Report filed | Mar 31, 2026 | Apr 7, 2025 | Apr 4, 2024 | Mar 22, 2023 | Apr 14, 2022 |
| Research and development | 6,227 | 5,698 | 7,274 | 5,587 | · |
| General and administrative | 4,858 | 4,204 | 4,775 | 4,967 | · |
| Total costs and expenses | · | · | · | 77 | 19 |
| Operating income | -11,085 | -9,902 | -12,049 | -10,554 | · |
| Total non-operating income (expense) | -40 | -308 | 1,942 | 62 | · |
| Net income | -11,125 | -10,210 | -10,107 | -10,492 | · |
| Earnings per share, basic | -0.44 | -0.54 | -0.74 | -0.91 | · |
| Earnings per share, diluted | -0.44 | -0.54 | -0.74 | -0.91 | · |
| Weighted average shares, basic | 25,481,343 | 18,602,082 | 13,640,168 | 11,504,521 | · |
| Weighted average shares, diluted | 25,481,343 | 18,602,082 | 13,640,168 | 11,504,521 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding